Demand high for antibiotics to combat Lyme bacteria that lingers, in some, long after completion of standard drug regimen Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a test they say will allow them to test thousands of FDA-approved drugs to see if they will work against the bacteria that causes tick-borne Lyme disease. The researchers, reporting Nov. [ 863 more words. ]
WWW.GORDONMEDICAL.COM
